Lila Sciences closed a $350 million Series A that brings Nvidia and other investors onto its cap table to fund development of systems that link AI models to physical measurement and sensing. The round funds Lila’s plans to commercialize embedded AI‑hardware stacks and scale lab‑connected sensing platforms. The startup is positioning itself at the intersection of AI, robotics and biosensing—an area attracting strategic interest as companies seek to translate generative models into real‑world experimental controls. Lila’s capital infusion reflects investor conviction that integrating AI with instrumentation and edge compute can accelerate wet‑lab throughput and reproducibility. Backers and customers will watch early partnerships and technical milestones—particularly demonstrations of closed‑loop experimental control and reliability across biological assays.